Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy/chemoimmunotherapy by Robak, Tadeusz, Doubek, Michael, Ferrant, Emmanuelle, Diels, Joris, Andersone, Liva, Wilbertz, Sabine, Healy, Nollaig C, Neumayr, Lynne, van Sanden, Suzy

Get full text

Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program by Hillmen, Peter, Diels, Joris, Healy, Nollaig, Iraqi, Wafae, Aschan, Johan, Wildgust, Mark

Get full text

PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome by Bowe, Rachael A, Cox, Orla T, Ayllón, Verónica, Tresse, Emilie, Healy, Nollaig C, Edmunds, Shelley J, Huigsloot, Merei, O'Connor, Rosemary

Get full text

Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth by Loughran, Gary, Healy, Nollaig C, Kiely, Patrick A, Huigsloot, Merei, Kedersha, Nancy L, O'Connor, Rosemary

Get full text

PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer by Cox, Orla T, Edmunds, Shelley J, Simon-Keller, Katja, Li, Bo, Moran, Bruce, Buckley, Niamh E, Bustamante-Garrido, Milan, Healy, Nollaig, O'Flanagan, Ciara H, Gallagher, William M, Kennedy, Richard D, Bernards, René, Caldas, Carlos, Chin, Suet-Feung, Marx, Alexander, O'Connor, Rosemary

Get full text

Comparative Effectiveness of Single-Agent Ibrutinib in the Ray Trial Versus Real-World Treatment in the Lyon-Sud Database in Patients with Relapsed or Refractory Mantle Cell Lympho... by Sarkozy, Clementine, Traverse-Glehen, Alexandra, Bachy, Emmanuel, Karlin, Lionel, Ghesquières, Hervé, Besson, Hervé, Hermans, Ruben, Healy, Nollaig, Garside, Jamie, Diels, Joris, MacDougall, Finlay, Pick-Lauer, Corinna, Salles, Gilles

Get full text

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia by Salles, Gilles, Bachy, Emmanuel, Smolej, Lukas, Simkovic, Martin, Baseggio, Lucile, Panovska, Anna, Besson, Hervé, Healy, Nollaig, Garside, Jamie, Iraqi, Wafae, Diels, Joris, Pick-Lauer, Corinna, Spacek, Martin, Urbanova, Renata, Lysak, Daniel, Hermans, Ruben, Lundbom, Jessica, Callet-Bauchu, Evelyne, Doubek, Michael

Get full text

Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONA... by Salles, Gilles A., Baseggio, Lucile, Bachy, Emmanuel, Sarkozy, Clementine, Ghesquieres, Herve, Diels, Joris, Besson, Hervé, MacDougall, Finlay, Hermans, Ruben, Healy, Nollaig, Garside, Jamie, Iraqi, Wafae, Callet-Bauchu, Evelyne

Get full text

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases by Salles, Gilles, Smolej, Lukas, Bachy, Emmanuel, Baseggio, Lucile, Besson, Hervé, Hermans, Ruben, Healy, Nollaig, Garside, Jamie, Iraqi, Wafae, Diels, Joris, MacDougall, Finlay, Pick-Lauer, Corinna, Spacek, Martin, Urbanova, Renata, Lysak, Daniel, Callet-Bauchu, Evelyne, Doubek, Michael

Get full text

PHEDRA: using real-world data to analyze treatment patterns and ibrutinib effectiveness in hematological malignancies by Garside, Jamie, Healy, Nollaig, Besson, Hervé, Hermans, Ruben, MacDougall, Finlay, Lestelle, Damien, Diels, Joris, Iraqi, Wafae

Get full text

Mystique Is a New Insulin-like Growth Factor-I-regulated PDZ-LIM Domain Protein That Promotes Cell Attachment and Migration and Suppresses Anchorage-independent GrowthD by Loughran, Gary, Healy, Nollaig C., Kiely, Patrick A., Huigsloot, Merei, Kedersha, Nancy L., O'Connor, Rosemary

Get full text

Vitamin D status & associations with inflammation in older adults by Laird, Eamon, O'Halloran, Aisling M, Molloy, Anne M, Healy, Martin, Bourke, Nollaig, Kenny, Rose Anne

Get full text